Prosecution Insights
Last updated: April 19, 2026

Examiner: DROUIN, STEVE HOANG

Tech Center 1600 • Art Units: 1627

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
5
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
25.0%
§102 Novelty
62.5%
§103 Obviousness
12.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18362485 METHODS AND COMPOSITIONS FOR INHIBITION OF NEUTROPHIL RECRUITMENT IN MYCOCARDIAL ISCHEMIA-REPERFUSION INJURY Non-Final OA University of Connecticut
18355219 USE OF SMO INHIBITOR IN PREPARATION OF DRUG FOR PREVENTING, DELAYING OR ALLEVIATING ACCESS STENOSIS OF ARTERIOVENOUS FISTULA Non-Final OA JINAN UNIVERSITY
18361492 METHODS OF TREATING A CORONAVIRUS INFECTION Non-Final OA City of Hope
18227402 CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3-(TETRAHYDRO-2H-PYRAN-4-YL)-5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE Non-Final OA MYOKARDIA, INC.
18354910 Uses of Dihydroorotate Dehydrogenase Inhibitors Non-Final OA University of Maryland, Baltimore

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month